Brief: Tetra Bio-Pharma Announces Joint Venture With Thorne And Onegevity Health To Form CB2 Therapeutics

Tetra Bio Pharma

21/08/2019 12:01

Aug 21 (Reuters) - Tetra Bio Pharma Inc  TBP.V :
    * TETRA BIO-PHARMA ANNOUNCES JOINT VENTURE WITH THORNE AND
ONEGEVITY HEALTH TO FORM CB2 THERAPEUTICS
    * TETRA BIO PHARMA INC - SIGNED AN AGREEMENT WITH THORNE
RESEARCH
INC. AND ONEGEVITY HEALTH LLC TO FORM JV
    * TETRA BIO PHARMA INC - ALL PARTIES GRANT JV AN EXCLUSIVE,
FULLY-PAID, ROYALTY-FREE LICENSE TO USE THEIR RESPECTIVE
INTELLECTUAL PROPERTY
    * TETRA BIO PHARMA INC - JOINT VENTURE IS TARGETING AN
INITIAL
RAISE OF $10 MILLION TO COMMENCE ITS PHASE 2 CLINICAL TRIALS

Source text for Eikon:  ID:nGNXbhlxfm 
Further company coverage:  TBP.V 

 ((Reuters.Briefs@thomsonreuters.com;))